Earnings Call · Q2 FY2023·2023-08-01

Q2 23EPS +13.79%·Rev n/aQ1 23EPS -50.00%·Rev n/aQ4 22EPS +8.77%·Rev n/aQ3 22EPS -15.49%·Rev n/a⚠ consensus missing

INCYTE CORP INCY

Greg Shertzer — Head of Investor Relations

Herve Hoppenot — Chairman, President and Chief Executive Officer

Pablo Cagnoni — President and Head of Research & Development

Barry Flannelly — Executive Vice President and General Manager, North America

Steven Stein — Chief Medical Officer

Christiana Stamoulis — Chief Financial Officer

0.0%1d on move date+0.2% vs SPY3d+2.0%5d+1.9%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more INCY calls or request research access.

More INCY calls Browse calls Request research access